In humans, pseudogene-derived mutations transferred to CYP21A2 by gene conversion or promoter alterations can result in non-classical congenital adrenal hyperplasia (NC-CAH), with measurable effects on transcriptional efficiency [26]. Here, CYP21A2 is linked to congenital adrenal hyperplasia.